These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 33503342)

  • 1. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
    Turok DK; Gero A; Simmons RG; Kaiser JE; Stoddard GJ; Sexsmith CD; Gawron LM; Sanders JN
    N Engl J Med; 2021 Jan; 384(4):335-344. PubMed ID: 33503342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.
    Turok DK; Sanders JN; Thompson IS; Royer PA; Eggebroten J; Gawron LM
    Contraception; 2016 Jun; 93(6):526-32. PubMed ID: 26944863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: Implications for backup contraception recommendations.
    Fay KE; Clement AC; Gero A; Kaiser JE; Sanders JN; BakenRa AA; Turok DK
    Contraception; 2021 Nov; 104(5):561-566. PubMed ID: 34166648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception.
    Sanders JN; Turok DK; Royer PA; Thompson IS; Gawron LM; Storck KE
    Contraception; 2017 Aug; 96(2):99-105. PubMed ID: 28596121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception.
    Sanders JN; Howell L; Saltzman HM; Schwarz EB; Thompson IS; Turok DK
    Am J Obstet Gynecol; 2016 Nov; 215(5):592.e1-592.e5. PubMed ID: 27349294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for emergency contraception.
    Shen J; Che Y; Showell E; Chen K; Cheng L
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD001324. PubMed ID: 28766313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for emergency contraception.
    Shen J; Che Y; Showell E; Chen K; Cheng L
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD001324. PubMed ID: 30661244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: a randomized controlled trial.
    Kaiser JE; Turok DK; Gero A; Gawron LM; Simmons RG; Sanders JN
    Am J Obstet Gynecol; 2023 Apr; 228(4):438.e1-438.e10. PubMed ID: 36427600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
    Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates.
    Turok DK; Jacobson JC; Dermish AI; Simonsen SE; Gurtcheff S; McFadden M; Murphy PA
    Contraception; 2014 Mar; 89(3):222-8. PubMed ID: 24332433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception.
    BakenRa A; Gero A; Sanders J; Simmons R; Fay K; Turok DK
    Obstet Gynecol; 2021 Jul; 138(1):79-84. PubMed ID: 34259467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching and discontinuation of participant-masked randomization to a copper or levonorgestrel intrauterine device when presenting for emergency contraception.
    Kaplan J; Turok DK; Gero A; Kaiser JE; Simmons RG; Fay KE
    Contraception; 2023 Feb; 118():109893. PubMed ID: 36240903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestin intrauterine devices versus copper intrauterine devices for emergency contraception.
    Ramanadhan S; Goldstuck N; Henderson JT; Che Y; Cleland K; Dodge LE; Edelman A
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013744. PubMed ID: 36847591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
    Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
    Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
    Turok DK; Godfrey EM; Wojdyla D; Dermish A; Torres L; Wu SC
    Hum Reprod; 2013 Oct; 28(10):2672-6. PubMed ID: 23945595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J; Lähteenmäki P
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.